HCP Cureblindness has provided 200,000+ sight-saving corneal transplants since 2009.
The acquisition will reunite the great community that Italia Independent has created over the years.
“We’re honored to carry on Dr. Bjork and Dr. Fisher’s legacy and allow them to continue focusing on what matters most – caring for their patients,”...
$8.5 billion deal to unite six luxury brands
Supported by proprietary hardware and software, the Company aims to eliminate the stigma associated with traditional hearing solutions.
Transaction Includes U.S. and Canadian Commercial Rights to FLAREX, NATACYN, TOBRADEX ST, VERKAZIA, ZERVIATE, and Non-Prescription Brands FRESHKOTE and Cationorm PLUS.
VEVYE is the first and only cyclosporine-based product indicated for the treatment of both signs and symptoms of dry eye disease with efficacy demonstrated after four...
Marcolin, a worldwide leading group in the eyewear industry, announces it has completed the acquisition of its own subsidiary in México.
ICU's products include over-the-counter reading glasses, sunglasses, blue light blocking eyewear, sun readers and outdoor specialty sunglasses.
The AcuFocus IC-8 Apthera IOL is approved in the U.S. for treatment of cataracts.
The deal "is part of De Rigo's strategic plan for further international expansion and growth in the premium eyewear segment."
The purchase includes Tyrvaya, for the treatment of dry eye disease.
William Morris London designs optical and sunglass frames.
Through the transaction, Alcon will add the products Rocklatan and Rhopressa and several product candidates.
Combined, the nonprofit will be the largest eye bank, tissue recovery and ocular research center in the world.
EnsEyes has partnered with customers in Denmark, Sweden, Norway and Finland for the past decade, providing customized lenses and professional education.
The company is being sold by Atlantic Street Capital.
The goal is to 'connect consumers and eyecare professionals without friction.'
Deal "introduces a new line of prestigious products and services to be made available to our customers," says CEO of Advancing Eyecare.
The deal is reportedly for $7.6 million.
Get the most important news and business ideas for eyecare professionals every weekday from INVISION.
Advertisement
